BioXcel Therapeutics Reports Q3 2024 Financial Results

Nov 15, 2024 · BioXcel Therapeutics reports Q3 EPS (32c), consensus (48c) TipRanks 6d BioXcel Therapeutics GAAP EPS of -$0.32 beats by $0.23, revenue of $0.21M misses by $1.12M

CouponFollow Extension

$0.32
OFF

BioXcel Therapeutics Reports Q3 2024 Financial Results

6 days from now

Nov 15, 2024 · BioXcel Therapeutics reports Q3 EPS (32c), consensus (48c) TipRanks 6d BioXcel Therapeutics GAAP EPS of -$0.32 beats by $0.23, revenue of $0.21M misses by $1.12M

businessinsider.com

89%
OFF

BioXcel Therapeutics Inc (BTAI) Q3 2024 Earnings Call Highlights ...

6 days from now

Nov 15, 2024 · Net Revenue for IGALMI: $214,000 for Q3 2024, compared to $341,000 for Q3 2023. Net Revenue for Nine Months Ended September 30, 2024: $1.9 million, an 89% …

yahoo.com

$214
OFF

BioXcel Therapeutics Reports Q3 2024 Financial Results

6 days from now

Key financial metrics show that BioXcel Therapeutics recorded net revenue of $214 thousand for the third quarter of 2024, a decrease from the previous year, attributed to the timing of re …

tipranks.com

$214
OFF

BioXcel Therapeutics Reports Third Quarter 2024 Financial Results

6 days from now

Nov 14, 2024 · Third Quarter 2024 Financial Results . Net Revenue: Net revenue from IGALMI was $214 thousand for the third quarter of 2024, compared to $341 thousand for the same …

yahoo.com

$214
OFF

BioXcel Therapeutics Inc Reports Q3 2024 Earnings: Net Revenue A

6 days from now

Net Revenue: Reported $214 thousand for Q3 2024, falling short of the estimated $0.76 million, and down from $341 thousand in Q3 2023.Cost of Goods Sold: Incre ... Key Insights from …

gurufocus.com

$214
OFF

BioXcel Therapeutics Inc. - MarketWatch

6 days from now

4 days ago · BioXcel Therapeutics Inc Reports Q3 2024 Earnings: Net Revenue at $214K, Net Loss Narrows to $13.7M Nov. 14, 2024 at 7:35 a.m. ET on GuruFocus.com BioXcel …

marketwatch.com

36%
OFF

BioXcel Therapeutics, Inc. (BTAI) Reports Q3 Loss, Lags Revenue ...

6 days from now

Nov 14, 2024 · BioXcel Therapeutics (BTAI) delivered earnings and revenue surprises of 36% and 82.17%, respectively, for the quarter ended September 2024. Do the numbers hold clues …

zacks.com

$13
OFF

BioXcel Therapeutics, Inc. (BTAI) Q3 2024 Earnings Call Transcript

6 days from now

Nov 14, 2024 · BioXcel Therapeutics had a net loss of $13.7 million for the third quarter of 2024, compared to a net loss of $50.5 million for the same period in 2023. Company used $16.3 …

seekingalpha.com

$13
OFF

BioXcel Therapeutics, Inc. (NASDAQ:BTAI) Q3 2024 Earnings Call

6 days from now

BioXcel Therapeutics had a net loss of $13.7 million for the third quarter of 2024, compared to a net loss of $50.5 million for the same period in 2023. Company used $16.3 million in operating ...

msn.com

$1.31
OFF

What To Expect From BioXcel Therapeutics Inc (BTAI) Q3 2024 …

6 days from now

Nov 13, 2024 · BioXcel Therapeutics Inc (NASDAQ:BTAI) is set to release its Q3 2024 earnings on Nov 14, 2024. The consensus estimate for Q3 2024 revenue is $1.31 million, and the …

yahoo.com

$7
OFF

BioXcel Therapeutics Announces Pricing Of $7M Public Offering

6 days from now

1 day ago · BioXcel Therapeutics, Inc. (BTAI) Q3 2024 Earnings Call Transcript; BioXcel announces common stock and warrants offering, no amount given; BioXcel Therapeutics …

seekingalpha.com

$0.51
OFF

Janux Therapeutics (JANX) Earnings Date And Reports 2024

6 days from now

2 days ago · Janux Therapeutics announced Q3 2024 earnings on November 6, 2024, reporting an EPS of -$0.51, which missed the consensus estimate of -$0.33 by $0.18. Quarterly revenue …

marketbeat.com

4%
OFF

New Jersey MarketBeats | US | Cushman & Wakefield

6 days from now

Oct 8, 2024 · Q3 2024 New Jersey Industrial Report. In New Jersey industrial market, leasing grew by 19.4% quarter-over-quarter (QOQ), totaling 8.0 million square feet (msf) and bringing …

cushmanwakefield.com

$16
OFF

Omega Therapeutics Reports Third Quarter 2024 Results

6 days from now

4 days ago · In its latest earnings report, Omega Therapeutics reported a net loss of $16.4 million for the third quarter of 2024, with collaboration revenue reaching $2.6 million, compared to …

businessinsider.com

$7
OFF

Heron Therapeutics Inc (HRTX) Q3 2024 Earnings Call Highlights ...

6 days from now

Nov 13, 2024 · Total Acute Care Net Revenues: $7.4 million for the quarter. ZYNRELEF Net Revenues: $6.3 million for the quarter. Oncology Franchise - CINVANTI Net Revenues: $22.6 …

yahoo.com

$1.83
OFF

Soleno Therapeutics (SLNO) Earnings Date And Reports 2024

6 days from now

2 days ago · Soleno Therapeutics announced Q3 2024 earnings on November 6, 2024, reporting an EPS of -$1.83, which missed analysts' consensus estimates of -$0.61 by $1.22. With a …

marketbeat.com

FAQs about BioXcel Therapeutics Reports Q3 2024 Financial Results Coupon?

How did bioxcel Therapeutics perform in the third quarter of 2024?

Key financial metrics show that BioXcel Therapeutics recorded net revenue of $214 thousand for the third quarter of 2024, a decrease from the previous year, attributed to the timing of re-orders. However, the net revenue for the first nine months of 2024 showed an 89% increase compared to the same period in 2023. ...

What time will bioxcel Therapeutics' financial results be released?

Conferencecallset for 8:00a.m.ETtoday NEW HAVEN, Conn., Nov. 14, 2024 (GLOBE NEWSWIRE) -- BioXcel Therapeutics, Inc. (Nasdaq: BTAI), a biopharmaceutical company utilizing artificial intelligence to develop transformative medicines in neuroscience, today announced its financial results for the third quarter of 2024. ...

Is bioxcel Therapeutics a biopharmaceutical company?

NEW HAVEN, Conn., Nov. 14, 2024 (GLOBE NEWSWIRE) -- BioXcel Therapeutics, Inc. (Nasdaq: BTAI), a biopharmaceutical company utilizing artificial intelligence to develop transformative medicines in neuroscience, today announced its financial results for the third quarter of 2024. ...

How do I contact bioxcel Therapeutics?

Visit www.fda.gov/medwatchor call 1-800-FDA-1088. You can also contact BioXcel Therapeutics, Inc. at 1-833-201- 1088 or [email protected]. Please see full Prescribing Information. About BXCL501 ...

What is the target price for bioxcel Therapeutics Inc (btai)?

After releasing the results, BioXcel Therapeutics Inc (NASDAQ:BTAI) was up by 4.34% in one day. Based on the one-year price targets offered by 6 analysts, the average target price for BioXcel Therapeutics Inc (NASDAQ:BTAI) is $6.50 with a high estimate of $18 and a low estimate of $1. ...

How do I access a live call from bioxcel Therapeutics?

To access the call, please dial 877-407-5795 or 201-689-8722. A live webcast will be available on the Investors section of the corporate website, bioxceltherapeutics.com and a replay will be available for 90 days. BioXcel Therapeutics may use its website as a distribution channel of material information about the Company. ...